Escape viral sintomático en el sistema nervioso central durante monoterapia con darunavir

Fuente Moral, Sara de la; Díaz de Santiago, Alberto; Ángel-Moreno Maroto, Alfonso.
Med. clín (Ed. impr.) ; 151(3): 128-129, ago. 2018.
Artículo en Español | IBECS (España) | ID: ibc-173858

Documentos relacionados

  1. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
  2. Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
  3. CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.
  4. A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.
  5. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
  6. STING is required for host defense against neuropathological West Nile virus infection.
  7. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
  8. Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir.
  9. Immune surveillance and response to JC virus infection and PML.
  10. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.